Medical Developments International LtdShs Aktie
| 0,32USD | -0,19USD | -36,84% |
WKN: A0BLXB / ISIN: AU000000MVP2
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 68 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,37 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. AUD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 47 | 34 | 43 | 26 | 36 |
| Summe Anlagevermögen | 53 | 67 | 67 | 38 | 35 |
| Summe Aktiva | 100 | 101 | 109 | 64 | 71 |
Bilanz (in Mio. AUD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 32 | 44 | 28 | 18 | 16 |
| Summe Eigenkapital | 68 | 57 | 81 | 46 | 55 |
| Summe Passiva | 100 | 101 | 109 | 64 | 71 |
Adresse
| 4 Caribbean Drive, 3179 Scoresby | |
| Telefon | +61 (3) 9547-1888 |
| Fax | +61 (3) 9547-0262 |
| Internet | http://www.medicaldev.com |
Management
|
Anastasia Tan
Head-Operations & Supply Chain |
|
Anita James
Chief Financial Officer |
|
Brent MacGregor
Chief Executive Officer |
|
Christine Emmanuel-Donnelly
Independent Non-Executive Director |
|
Damian Meagher
Head-Quality & Regulatory Affairs |
|
Gordon Naylor
Non-Executive Chairman |
|
Leon Gregory Hoare
Independent Non-Executive Director |
|
Mark Fladrich
Non-Executive Director |
|
Paul Ronald Townsend
Non-Executive Director |
|
Russell Basser
Director |
|
Scott Courtney
Chief Scientific Officer |
|
Sue Anne Yee
Head-Medical Affairs & Clinical Development |
|
Tara Eaton
Secretary & General Counsel |
|
Tony Wheal
Head-People & Culture |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.